BioIntelliSense Teams Up with Hicuity Health for Scalable Continuous Patient Monitoring BioIntelliSense, a leader in continuous health monitoring and clinical intelligence, has announced a strategic partnership with Hicuity Health, a…
LimmaTech Begins Phase 1 Trial of Staphylococcus aureus Vaccine LBT-SA7 LimmaTech Biologics AG, a clinical-stage biotech company focused on developing vaccines for life-threatening diseases, announced the vaccination of the first…
Innate Pharma’s Lacutamab Receives FDA Breakthrough Therapy Designation for Sézary Syndrome Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) has announced that the U.S. Food and Drug Administration (FDA) has…
Five-Year Sotyktu (Deucravacitinib) Data Show Consistent Safety and Durable Response in Psoriasis Bristol Myers Squibb (NYSE:BMY) has announced new five-year data from the POETYK PSO long-term extension (LTE) trial, evaluating…
CSL and Arcturus’ KOSTAIVE® Self-amplifying mRNA COVID-19 Vaccine Approved by European Commission CSL (ASX: CSL; USOTC: CSLLY), a global biotechnology leader, and Arcturus Therapeutics (Nasdaq: ARCT), a pioneer in self-amplifying…
Galderma’s Nemluvio® (Nemolizumab) EU Approval for Atopic Dermatitis and Prurigo Nodularis Galderma announced that the European Commission has granted approval for Nemluvio® (nemolizumab) for the treatment of moderate-to-severe atopic dermatitis…
Prolific Machines Appoints Christina Perry as CFO to Drive Biopharmaceutical Growth Prolific Machines, a leading biotechnology company specializing in using light to control biological processes, has announced the appointment of…
GeneDx Launches 48-Hour Whole Genome Sequencing for Critical NICU and PICU Patients GeneDx (Nasdaq: WGS), a leader in genomic health insights, has unveiled ultraRapid Whole Genome Sequencing, providing quick, comprehensive…
Ensoma Gets Pediatric Disease and Orphan Drug Designations for EN-374 in Chronic Granulomatous Disease Ensoma, a genomic medicines company focused on developing one-time, in vivo treatments to precisely and durably…
Latent Labs Raises $50M to Advance AI-Powered Programmable Biology Latent Labs, an AI-driven biotechnology company, has emerged from stealth mode with $50 million in total funding to accelerate its development…
Study Confirms Lubrizol’s MAGSHAPE™ Enhances Magnesium Absorption Lubrizol’s MAGSHAPE™ microcapsules, a micronized and microencapsulated form of magnesium, have been shown in a recent study to significantly enhance magnesium absorption compared…
Seaport Therapeutics Publishes Research on 55% Drug Absorption via Lymphatics with Glyph™ Platform Seaport Therapeutics, a clinical-stage biopharmaceutical company focused on developing innovative neuropsychiatric medicines, has announced the publication of…